Simian Immunodeficiency Virus SIVrcm, a Unique CCR2-Tropic Virus, Selectively Depletes Memory CD4 (cid:1) T Cells in Pigtailed Macaques through Expanded Coreceptor Usage In Vivo (cid:1)

Simian immunodeficiency virus SIVrcm, which naturally infects red-capped mangabeys (RCMs), is the only SIV that uses CCR2 as its main coreceptor due to the high frequency of a CCR5 deletion in RCMs. We investigated the dynamics of SIVrcm infection to identify specific pathogenic mechanisms associated with this major difference in SIV biology. Four pigtailed macaques (PTMs) were infected with SIVrcm, and infection was monitored for over 2 years. The dynamics of in vivo SIVrcm replication in PTMs was similar to that of other pathogenic and nonpathogenic lymphotropic SIVs. Plasma viral loads (VLs) peaked at 10 7 to 10 9 SIVrcm RNA copies/ml by day 10 postinoculation (p.i.). A viral set point was established by day 42 p.i. at 10 3 to 10 5 SIVrcm RNA copies/ml and lasted up to day 180 p.i., when plasma VLs decreased below the threshold of detection, with blips of viral replication during the follow-up. Intestinal SIVrcm replication paralleled that of plasma VLs. Up to 80% of the CD4 (cid:1) T cells were depleted by day 28 p.i. in the gut. The most significant depletion (>90%) involved memory CD4 (cid:1) T cells. Partial CD4 (cid:1) T-cell restoration was observed in the intestine at later time points. Effector memory CD4 (cid:1) T cells were the least restored. SIVrcm strains isolated from acutely infected PTMs used CCR2 coreceptor, as reported, but expansion of coreceptor usage to CCR4 was also observed. Selective depletion of effector memory CD4 (cid:1) T cells is in contrast with predicted in vitro tropism of SIVrcm for macrophages and is probably due to expansion of coreceptor usage. Taken together, these findings emphasize the importance of understanding the selective forces driving viral adaptation to a new host.

[1]  Aarti Gautam,et al.  Cutting Edge: Experimentally Induced Immune Activation in Natural Hosts of Simian Immunodeficiency Virus Induces Significant Increases in Viral Replication and CD4+ T Cell Depletion1 , 2008, The Journal of Immunology.

[2]  B. Ling,et al.  Nonpathogenic CCR2-tropic SIVrcm after serial passage and its effect on SIVmac infection of Indian rhesus macaques. , 2008, Virology.

[3]  N. Haigwood,et al.  The Use of Nonhuman Primate Models in HIV Vaccine Development , 2008, PLoS medicine.

[4]  S. Hammer,et al.  HIV Vaccine Research: The Way Forward , 2008, Science.

[5]  John P. Moore,et al.  Nonhuman primate models and the failure of the Merck HIV-1 vaccine in humans , 2008, Nature Medicine.

[6]  Ruchi M. Newman,et al.  Evolution of a TRIM5-CypA Splice Isoform in Old World Monkeys , 2008, PLoS pathogens.

[7]  A. Perelson,et al.  Short-Lived Infected Cells Support Virus Replication in Sooty Mangabeys Naturally Infected with Simian Immunodeficiency Virus: Implications for AIDS Pathogenesis , 2008, Journal of Virology.

[8]  A. Perelson,et al.  Simian Immunodeficiency Virus SIVagm Dynamics in African Green Monkeys , 2008, Journal of Virology.

[9]  Shiu-Lok Hu,et al.  Novel TRIM5 Isoforms Expressed by Macaca nemestrina , 2007, Journal of Virology.

[10]  A. Perelson,et al.  Acute Loss of Intestinal CD4+ T Cells Is Not Predictive of Simian Immunodeficiency Virus Virulence1 , 2007, The Journal of Immunology.

[11]  C. Apetrei,et al.  In vitro characterization of primary SIVsmm isolates belonging to different lineages. In vitro growth on rhesus macaque cells is not predictive for in vivo replication in rhesus macaques. , 2007, Virology.

[12]  Ronald S Veazey,et al.  Paucity of CD4 (cid:1) CCR5 (cid:1) T cells is a typical feature of natural SIV hosts , 2022 .

[13]  Sue VandeWoude,et al.  Going Wild: Lessons from Naturally Occurring T-Lymphotropic Lentiviruses , 2006, Clinical Microbiology Reviews.

[14]  C. Apetrei,et al.  Simian immunodeficiency viruses replication dynamics in African non‐human primate hosts: common patterns and species‐specific differences , 2006, Journal of medical primatology.

[15]  F. Barré-Sinoussi,et al.  Simian Immunodeficiency Virus SIVagm.sab Infection of Caribbean African Green Monkeys: a New Model for the Study of SIV Pathogenesis in Natural Hosts , 2006, Journal of Virology.

[16]  A. Wurcel,et al.  CD16+ Monocyte-Derived Macrophages Activate Resting T Cells for HIV Infection by Producing CCR3 and CCR4 Ligands1 , 2006, The Journal of Immunology.

[17]  D. Robertson,et al.  Kuru experiments triggered the emergence of pathogenic SIVmac. , 2006, AIDS.

[18]  Charles R. Brown,et al.  Immunodeficiency in the Absence of High Viral Load in Pig-Tailed Macaques Infected with Simian Immunodeficiency Virus SIVsun or SIVlhoest , 2005, Journal of Virology.

[19]  J. Mascola,et al.  Pathogenicity of Simian-Human Immunodeficiency Virus SHIV-89.6P and SIVmac Is Attenuated in Cynomolgus Macaques and Associated with Early T-Lymphocyte Responses , 2005, Journal of Virology.

[20]  R. Siliciano,et al.  SIV‐specific T lymphocyte responses in PBMC and lymphoid tissues of SIV‐infected pigtailed macaques during suppressive combination antiretroviral therapy , 2005, Journal of medical primatology.

[21]  Shiu-Lok Hu Non-human primate models for AIDS vaccine research. , 2005, Current drug targets. Infectious disorders.

[22]  F. Barré-Sinoussi,et al.  Impact of Viral Factors on Very Early In Vivo Replication Profiles in Simian Immunodeficiency Virus SIVagm-Infected African Green Monkeys , 2005, Journal of Virology.

[23]  Mario Roederer,et al.  Massive infection and loss of memory CD4+ T cells in multiple tissues during acute SIV infection , 2005, Nature.

[24]  Charles R. Brown,et al.  Plateau Levels of Viremia Correlate with the Degree of CD4+-T-Cell Loss in Simian Immunodeficiency Virus SIVagm-Infected Pigtailed Macaques: Variable Pathogenicity of Natural SIVagm Isolates , 2005, Journal of Virology.

[25]  William J. Kaiser,et al.  Divergent Host Responses during Primary Simian Immunodeficiency Virus SIVsm Infection of Natural Sooty Mangabey and Nonnatural Rhesus Macaque Hosts , 2005, Journal of Virology.

[26]  Hua Yang,et al.  Detection of Human Immunodeficiency Virus Type 1 DNA in Dried Blood Spots by a Duplex Real-Time PCR Assay , 2005, Journal of Clinical Microbiology.

[27]  S. Hughes,et al.  In Vitro Characterization of a Simian Immunodeficiency Virus-Human Immunodeficiency Virus (HIV) Chimera Expressing HIV Type 1 Reverse Transcriptase To Study Antiviral Resistance in Pigtail Macaques , 2004, Journal of Virology.

[28]  R. Desrosiers,et al.  Cell tropism of simian immunodeficiency virus in culture is not predictive of in vivo tropism or pathogenesis. , 2004, The American journal of pathology.

[29]  S. Staprans,et al.  The roles of nonhuman primates in the preclinical evaluation of candidate AIDS vaccines , 2004, Expert review of vaccines.

[30]  B. Gazzard,et al.  Where does HIV live? , 2004, The New England journal of medicine.

[31]  C. M. Owens,et al.  The cytoplasmic body component TRIM5α restricts HIV-1 infection in Old World monkeys , 2004, Nature.

[32]  L. White,et al.  High levels of SIVmnd-1 replication in chronically infected Mandrillus sphinx. , 2003, Virology.

[33]  J. Lifson,et al.  SIVmac pathogenesis in rhesus macaques of Chinese and Indian origin compared with primary HIV infections in humans , 2002, AIDS.

[34]  G. Shaw,et al.  Risk to Human Health from a Plethora of Simian Immunodeficiency Viruses in Primate Bushmeat , 2002, Emerging infectious diseases.

[35]  B. Foley,et al.  Characterization of Novel Simian Immunodeficiency Viruses from Red-Capped Mangabeys from Nigeria (SIVrcmNG409 and -NG411) , 2001, Journal of Virology.

[36]  J. Takehisa,et al.  Natural infection of wild-born mandrills (Mandrillus sphinx) with two different types of simian immunodeficiency virus. , 2001, AIDS research and human retroviruses.

[37]  F. Barré-Sinoussi,et al.  Synthetic peptide strategy for the detection of and discrimination among highly divergent primate lentiviruses. , 2001, AIDS research and human retroviruses.

[38]  K. Mansfield,et al.  Dynamics of CCR5 Expression by CD4+ T Cells in Lymphoid Tissues during Simian Immunodeficiency Virus Infection , 2000, Journal of Virology.

[39]  John P. Moore,et al.  Use of Inhibitors To Evaluate Coreceptor Usage by Simian and Simian/Human Immunodeficiency Viruses and Human Immunodeficiency Virus Type 2 in Primary Cells , 2000, Journal of Virology.

[40]  K. Tokunaga,et al.  New variations of human CC-chemokine receptors CCR3 and CCR4 , 1999, Genes and Immunity.

[41]  N. Pedersen,et al.  Isolation and partial characterization of a lentivirus from talapoin monkeys (Myopithecus talapoin). , 1999, Virology.

[42]  C. Blois-Heulin,et al.  Patterns of Social Visual Attention in the Red-Capped Mangabey (Cercocebus torquatus torquatus) in the Context of Food Competition , 1999, Folia Primatologica.

[43]  E. Hoover,et al.  Virus threshold determines disease in SIVsmmPBj14-infected macaques. , 1999, AIDS research and human retroviruses.

[44]  Alan S. Perelson,et al.  Rapid Clearance of Simian Immunodeficiency Virus Particles from Plasma of Rhesus Macaques , 1999, Journal of Virology.

[45]  D. Ho,et al.  Natural Infection of a Homozygous Δ24 CCR5 Red-capped Mangabey with an R2b-Tropic Simian Immunodeficiency Virus , 1998, The Journal of experimental medicine.

[46]  R. Means,et al.  Diverse Host Responses and Outcomes following Simian Immunodeficiency Virus SIVmac239 Infection in Sooty Mangabeys and Rhesus Macaques , 1998, Journal of Virology.

[47]  S. Engelbrecht,et al.  Simian immunodeficiency viruses (SIVs) from eastern and southern Africa: detection of a SIVagm variant from a chacma baboon. , 1998, The Journal of general virology.

[48]  H. Whittle,et al.  A Broad Range of Chemokine Receptors Are Used by Primary Isolates of Human Immunodeficiency Virus Type 2 as Coreceptors with CD4 , 1998, Journal of Virology.

[49]  A. Gettie,et al.  SIVrcm infection of macaques , 1998, Journal of medical primatology.

[50]  S. Kent,et al.  A minimally replicative HIV-2 live-virus vaccine protects M. nemestrina from disease after HIV-2(287) challenge. , 1998, Virology.

[51]  P. Gray,et al.  Macrophage-derived Chemokine Is a Functional Ligand for the CC Chemokine Receptor 4* , 1998, The Journal of Biological Chemistry.

[52]  Zhiwei Chen,et al.  Natural Infection of a Household Pet Red-Capped Mangabey (Cercocebus torquatus torquatus) with a New Simian Immunodeficiency Virus , 1998, Journal of Virology.

[53]  R. Means,et al.  Simian immunodeficiency virus variants with differential T-cell and macrophage tropism use CCR5 and an unidentified cofactor expressed in CEMx174 cells for efficient entry , 1997, Journal of virology.

[54]  O. Yoshie,et al.  The T Cell-directed CC Chemokine TARC Is a Highly Specific Biological Ligand for CC Chemokine Receptor 4* , 1997, The Journal of Biological Chemistry.

[55]  F. Bibollet-Ruche,et al.  Simian immunodeficiency virus infection in a patas monkey (Erythrocebus patas): evidence for cross-species transmission from African green monkeys (Cercopithecus aethiops sabaeus) in the wild. , 1996, The Journal of general virology.

[56]  A. Perelson,et al.  HIV-1 Dynamics in Vivo: Virion Clearance Rate, Infected Cell Life-Span, and Viral Generation Time , 1996, Science.

[57]  P. Johnson,et al.  Induction of AIDS by simian immunodeficiency virus from an African green monkey: species-specific variation in pathogenicity correlates with the extent of in vivo replication , 1995, Journal of virology.

[58]  P. Sharp,et al.  Infection of a yellow baboon with simian immunodeficiency virus from African green monkeys: evidence for cross-species transmission in the wild , 1994, Journal of virology.

[59]  J. Thompson,et al.  CLUSTAL W: improving the sensitivity of progressive multiple sequence alignment through sequence weighting, position-specific gap penalties and weight matrix choice. , 1994, Nucleic acids research.

[60]  P. Johnson,et al.  Pathogenic diversity of simian immunodeficiency viruses. , 1994, Virus research.

[61]  Mark G. Lewis,et al.  Adaptation of HIV‐1 to pigtailed macaques , 1994, Journal of medical primatology.

[62]  R. Lenroot,et al.  A distinct African lentivirus from Sykes' monkeys , 1993, Journal of virology.

[63]  M. Katze,et al.  Infection of Macaca nemestrina by human immunodeficiency virus type-1. , 1992, Science.

[64]  M. Gardner,et al.  A highly divergent simian immunodeficiency virus (SIVstm) recovered from stored stump-tailed macaque tissues , 1991, Journal of virology.

[65]  P. Fultz,et al.  Identification and biologic characterization of an acutely lethal variant of simian immunodeficiency virus from sooty mangabeys (SIV/SMM). , 1989, AIDS research and human retroviruses.

[66]  P. Fultz,et al.  Spectrum of disease in macaque monkeys chronically infected with SIV/SMM. , 1989, Veterinary immunology and immunopathology.

[67]  B. Gormus,et al.  Isolation of an HTLV-III-related retrovirus from macaques with simian AIDS and its possible origin in asymptomatic mangabeys , 1986, Nature.

[68]  K. Uberla Efficacy of AIDS vaccine strategies in nonhuman primates. , 2005, Medical microbiology and immunology.

[69]  B. Gormus,et al.  A brief history of the discovery of natural simian immunodeficiency virus (SIV) infections in captive sooty mangabey monkeys. , 2004, Frontiers in bioscience : a journal and virtual library.

[70]  J. Cohen AIDS research. Vaccine studies stymied by shortage of animals. , 2000, Science.

[71]  M. Brown,et al.  Inhibition of HIV-1 infection by the beta-chemokine MDC. , 1997, Science.

[72]  V. Polonis,et al.  HIV-1 infection in pigtailed macaques. , 1994, AIDS research and human retroviruses.